Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.
Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check13 days agoChange DetectedA Phase II study on the combination of Ponatinib with Mini-hyper CVD Chemotherapy and Venetoclax for T-cell Acute Lymphoblastic Leukemia has been updated to 'Active, not recruiting' with a new revision (v2.11.0), while the previous version (v2.10.5) has been removed.SummaryDifference6%
- Check20 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check56 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check77 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.